Endocrinology
News, opinions and meeting coverage in endocrinology.
鈥� SGLT1/SGLT2 inhibitor has another shot in T1D, but now in more narrow patient population
Latest in Endocrinology
Remission of coexisting conditions was also maintained, long-term data show
Patients taking the GLP-1 drug also had greater improvement in physical function
New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents
Public health and access to care are at stake in the 2024 election
New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents
Public health and access to care are at stake in the 2024 election
Endocrinology Case Studies
Alcoholism, liver dysfunction highly linked with rare disease of unknown etiology
Surgery may not always be the best option, case report finds
Diagnosis of this rare disease is often a challenge
More in Endocrinology
However, 24 weeks of the GLP-1 had no impact on eGFR
Also in TTHealthWatch: best medications for opioid use disorder
Median OS as high as 43 months with mutation-guided targeted agents plus immunotherapy
Testing could be useful for older women at higher risk
GLP-1 receptor agonists may have better protective benefits versus metformin, insulin
Large observational study suggests further research is warranted
Health news and commentary gathered by 番茄社区app staff
Interim analysis of small trial raises alarm about using progestins in particular prior to IVF
Findings leave researcher "concerned"
A notable 23.6% said they had concerns about their health or future fertility
News and commentary from the endocrinology world
Conundrum of holding meds continues following conflicting reports of aspiration events
Multiple birth rate plummeted after revamped single embryo transfer guidance in 2017
Health news and commentary gathered by 番茄社区app staff
